Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Study ID: NCT04181463
Start Date: 2025-11-05
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

112

Intervention / Treatment

Isopropyl Alcohol

Placebo

Administration Questionnaire

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Dopamine D3 Receptor Occupancy in Bipolar Depression

Study ID: NCT05060549
Start Date: 2026-01-06
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

8

Intervention / Treatment

Cariprazine

Sponsor

New York State Psychiatric Institute

Source: clinicaltrials.gov

Share:
Add to list

Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy

Study ID: NCT07207876
Start Date: 2025-11-30
End Date: 2027-05-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Ceftriaxone

Benzathine penicillin G

Sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Source: clinicaltrials.gov

Share:
Add to list

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

Study ID: NCT07162038
Start Date: 2025-11-09
End Date: 2034-10-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

155

Intervention / Treatment

mCD19-CAR-CD28-CD3-zeta.(anti-CD19 CAR) retroviral vector-transduced allogeneic peripheral blood lymphocytes (PBL)

Fludarabine

Cyclophosphamide

Mycophenolate Mofetil

Sirolimus

CD19 Flow Cytometry Assay

CD19 Immunohistochemical Assay

Total Body Irradiation

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Post Operative Hospital at Home After Colorectal Surgery

Study ID: NCT07113717
Start Date: 2025-12-15
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

virtual Hospital at Home

Sponsor

Nordsjaelland's Hospital

Source: clinicaltrials.gov

Share:
Add to list

The Impact of Light Exposure on Cognitive Function in Classrooms

Study ID: NCT06325150
Start Date: 2026-05-16
End Date: 2028-02-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

300

Intervention / Treatment

Light emitting glasses

Sponsor

Michigan State University

Source: clinicaltrials.gov

Share:
Add to list

Safety Profile of Psilocybin for Cocaine Use Disorder

Study ID: NCT06102434
Start Date: 2025-12
End Date: 2026-06
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

Psilocybin

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list

The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction

Study ID: NCT07103655
Start Date: 2026-01-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

132

Intervention / Treatment

activities

Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol

diltiazem

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Source: clinicaltrials.gov

Share:
Add to list

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

Study ID: NCT07214376
Start Date: 2025-12-01
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

750

Intervention / Treatment

Pulmonary Artery Denervation (PADN)

Sham procedure control

Sponsor

Pulnovo Medical, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Study ID: NCT07122089
Start Date: 2026-01-02
End Date: 2030-01-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Selective Internal Radiotherapy

Tremelimumab

Durvalumab

Sponsor

Center Eugene Marquis

Source: clinicaltrials.gov

Share:
Add to list